Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 14 9 2020
medline: 29 1 2021
entrez: 13 9 2020
Statut: ppublish

Résumé

COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular disease, or cardiovascular risk factors including noncontrolled diabetes mellitus or arterial hypertension, obesity, and advanced age. The VAS-European Independent Foundation in Angiology/Vascular Medicine draws attention to patients with vascular disease (VD) and presents an integral strategy for the management of patients with VD or cardiovascular risk factors (VD-CVR) and COVID-19. VAS recommends (1) a COVID-19-oriented primary health care network for patients with VD-CVR for identification of patients with VD-CVR in the community and patients' education for disease symptoms, use of eHealth technology, adherence to the antithrombotic and vascular regulating treatments, and (2) close medical follow-up for efficacious control of VD progression and prompt application of physical and social distancing measures in case of new epidemic waves. For patients with VD-CVR who receive home treatment for COVID-19, VAS recommends assessment for (1) disease worsening risk and prioritized hospitalization of those at high risk and (2) VTE risk assessment and thromboprophylaxis with rivaroxaban, betrixaban, or low-molecular-weight heparin (LMWH) for those at high risk. For hospitalized patients with VD-CVR and COVID-19, VAS recommends (1) routine thromboprophylaxis with weight-adjusted intermediate doses of LMWH (unless contraindication); (2) LMWH as the drug of choice over unfractionated heparin or direct oral anticoagulants for the treatment of VTE or hypercoagulability; (3) careful evaluation of the risk for disease worsening and prompt application of targeted antiviral or convalescence treatments; (4) monitoring of D-dimer for optimization of the antithrombotic treatment; and (5) evaluation of the risk of VTE before hospital discharge using the IMPROVE-D-dimer score and prolonged post-discharge thromboprophylaxis with rivaroxaban, betrixaban, or LMWH.

Identifiants

pubmed: 32920811
doi: 10.1055/s-0040-1715798
pmc: PMC7869052
doi:

Substances chimiques

Anticoagulants 0
Heparin, Low-Molecular-Weight 0
Rivaroxaban 9NDF7JZ4M3

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1597-1628

Investigateurs

Behnood Bikdeli (B)
Yutao Guo (Y)
Job Harenberg (J)
Yu Hu (Y)
Gregory Y H Lip (GYH)
Vanessa Roldan (V)

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Références

Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Blood Adv. 2018 Nov 27;2(22):3198-3225
pubmed: 30482763
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Am J Hypertens. 2020 Oct 21;33(10):944-948
pubmed: 32511678
Shock. 1998 Apr;9(4):274-81
pubmed: 9565256
N Engl J Med. 2013 Feb 7;368(6):513-23
pubmed: 23388003
J Am Soc Nephrol. 2020 Sep;31(9):1948-1958
pubmed: 32660970
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Thromb Haemost. 2020 Jul;120(7):1004-1024
pubmed: 32473596
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e244-e245
pubmed: 32294273
Pharmacol Res. 2020 Aug;158:104950
pubmed: 32450344
Arch Physiol Biochem. 2007 Oct-Dec;113(4-5):259-67
pubmed: 18158647
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Respir Care. 2020 Jul;65(7):1039-1045
pubmed: 32047121
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):8S-28S
pubmed: 30296833
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Br J Haematol. 2020 Jun;189(6):1044-1049
pubmed: 32330308
Crit Care. 2020 Jun 16;24(1):353
pubmed: 32546188
Int Angiol. 2013 Apr;32(2):111-260
pubmed: 24402349
J Thromb Haemost. 2020 Aug;18(8):2066-2067
pubmed: 32344457
Biochem Biophys Res Commun. 2007 Jul 20;359(1):174-9
pubmed: 17533109
J Thromb Haemost. 2018 Jul;16(7):1278-1287
pubmed: 29753308
Thromb Haemost. 2020 Dec;120(12):1680-1690
pubmed: 32961572
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
Clin Appl Thromb Hemost. 2008 Oct;14(4):385-92
pubmed: 18815137
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124
pubmed: 32387623
Postgrad Med J. 2020 Jul;96(1137):403-407
pubmed: 32522846
Pharmacol Res. 2017 Sep;123:146-156
pubmed: 28161237
Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006273
pubmed: 29954742
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Thromb Haemost. 2007 May;5(5):955-62
pubmed: 17461929
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Thromb Res. 2020 Aug;192:113-115
pubmed: 32425261
J Clin Invest. 2002 Jul;110(1):127-36
pubmed: 12093896
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Hamostaseologie. 2020 Aug;40(3):264-269
pubmed: 32498097
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530
pubmed: 32203680
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
Chest. 2012 Feb;141(2 Suppl):e195S-e226S
pubmed: 22315261
Crit Care Med. 2020 Sep;48(9):1358-1364
pubmed: 32467443
Molecules. 2020 May 29;25(11):
pubmed: 32485894
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Am J Ther. 2022 Jul 01;29(4):e385-e393
pubmed: 31833874
Thromb Haemost. 2016 Apr;115(4):712-28
pubmed: 26676884
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
TH Open. 2020 Mar 13;4(1):e59-e65
pubmed: 32190813
J Thromb Haemost. 2020 Jul;18(7):1743-1746
pubmed: 32320517
JAAD Case Rep. 2020 Apr 18;6(6):489-492
pubmed: 32363225
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Int J Legal Med. 2020 Jul;134(4):1275-1284
pubmed: 32500199
J Am Heart Assoc. 2014 Nov 17;3(6):e001152
pubmed: 25404191
Thromb Haemost. 2003 Mar;89(3):561-72
pubmed: 12624642
J Thromb Thrombolysis. 2020 Jul;50(1):211-216
pubmed: 32451823
J Thromb Haemost. 2020 Jul;18(7):1747-1751
pubmed: 32302448
Eur Heart J. 2020 May 14;41(19):1858
pubmed: 32227120
Circulation. 2020 Jun 9;141(23):1930-1936
pubmed: 32243205
J Thromb Haemost. 2020 Sep;18(9):2391-2399
pubmed: 32558198
Br J Haematol. 2020 Jun;189(5):846-847
pubmed: 32304577
Int Angiol. 2018 Aug;37(4):327-334
pubmed: 29936722
J Thromb Haemost. 2020 Jun;18(6):1324-1329
pubmed: 32306492
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
Arch Med Sci. 2020 Apr 25;16(3):490-496
pubmed: 32399094
Vasa. 2020 Mar;49(2):133-140
pubmed: 31808732
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Histopathology. 2020 Aug;77(2):198-209
pubmed: 32364264
Clin Exp Dermatol. 2020 Aug;45(6):746-748
pubmed: 32302422
Nephron. 2017;137(2):113-123
pubmed: 28662505
Pulm Ther. 2020 Dec;6(2):169-176
pubmed: 32405877
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
Br J Haematol. 2020 Jun;189(6):1060-1061
pubmed: 32400024
Thromb Res. 2020 Sep;193:86-89
pubmed: 32531548
BMJ. 2006 Feb 11;332(7537):325-9
pubmed: 16439370
Clin Pharmacokinet. 2018 Oct;57(10):1347-1354
pubmed: 29453687
Thromb Res. 2019 Feb;174:48-50
pubmed: 30554045
J Thromb Haemost. 2013 Feb 4;:
pubmed: 23379279
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e251-e252
pubmed: 32294270
Thromb Haemost. 2014 Nov;112(5):941-6
pubmed: 25030937
J Med Internet Res. 2020 Jun 12;22(6):e19938
pubmed: 32490843
Thromb Haemost. 2001 Nov;86(5):1327-30
pubmed: 11816725
Thromb Res. 2018 Apr;164 Suppl 1:S62-S69
pubmed: 29703486
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
J Am Heart Assoc. 2021 Jul 6;10(13):e018086
pubmed: 33624516
Res Pract Thromb Haemost. 2018 Jul 17;2(4):696-707
pubmed: 30349889
N Engl J Med. 1999 Sep 9;341(11):793-800
pubmed: 10477777
Lancet Infect Dis. 2020 Oct;20(10):1135-1140
pubmed: 32526193
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Radiology. 2020 Sep;296(3):E186-E188
pubmed: 32324103
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e246-e247
pubmed: 32294259
Clin Chem Lab Med. 2020 Jun 25;58(7):1029-1036
pubmed: 32406381
Res Pract Thromb Haemost. 2018 Nov 15;3(1):18-25
pubmed: 30656272
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
J Thromb Haemost. 2020 Jun;18(6):1320-1323
pubmed: 32329231
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Thromb Haemost. 2020 Jun;120(6):949-956
pubmed: 32349133
J Thromb Thrombolysis. 2021 Feb;51(2):446-453
pubmed: 33151461
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Virchows Arch. 2020 Sep;477(3):359-372
pubmed: 32642842
Int J Infect Dis. 2020 Jul;96:615-617
pubmed: 32502659
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Am Acad Dermatol. 2020 Aug;83(2):700
pubmed: 32283229
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619876030
pubmed: 31530176
Curr Atheroscler Rep. 2018 Feb 14;20(3):12
pubmed: 29445885
Atherosclerosis. 2020 Jan;293:92-93
pubmed: 31822359
J Vasc Surg. 2020 Dec;72(6):1864-1872
pubmed: 32360679
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
JAMA. 2001 Oct 17;286(15):1869-78
pubmed: 11597289
Am J Emerg Med. 2020 Jul;38(7):1504-1507
pubmed: 32317203
Res Pract Thromb Haemost. 2020 Jun 09;4(4):518-523
pubmed: 32542212
Biochem Biophys Rep. 2016 Sep;7:180-187
pubmed: 28758151
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
Radiology. 2020 Sep;296(3):E189-E191
pubmed: 32324102
Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):568-575
pubmed: 32486534
Curr Atheroscler Rep. 2004 Sep;6(5):381-7
pubmed: 15296705
Influenza Other Respir Viruses. 2017 Jan;11(1):85-92
pubmed: 27542891
J Thromb Haemost. 2020 Jul;18(7):1752-1755
pubmed: 32267998
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E197-E202
pubmed: 32501731
Lancet Infect Dis. 2020 Dec;20(12):1365-1366
pubmed: 32359410
Circulation. 2004 Aug 17;110(7):874-9
pubmed: 15289368
Pharmacol Rev. 2016 Jan;68(1):76-141
pubmed: 26672027
J Thromb Haemost. 2020 Aug;18(8):1995-2002
pubmed: 32369666
J Thromb Haemost. 2020 Aug;18(8):2058-2060
pubmed: 32324960
Blood. 1997 Nov 15;90(10):3819-43
pubmed: 9354649
Mem Inst Oswaldo Cruz. 2020;115:e200179
pubmed: 32490889
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
J Thromb Thrombolysis. 2020 Oct;50(3):543-547
pubmed: 32519165
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Chest. 2020 Sep;158(3):1143-1163
pubmed: 32502594
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e250-e251
pubmed: 32294264
Ann Hematol. 2020 Jul;99(7):1421-1428
pubmed: 32495027
Hosp Pract (1995). 2020 Oct;48(4):169-179
pubmed: 32429774
J Am Acad Dermatol. 2020 Jul;83(1):e57-e60
pubmed: 32339706
PLoS Biol. 2005 Oct;3(10):e324
pubmed: 16128623
J Thromb Thrombolysis. 2020 Jul;50(1):72-81
pubmed: 32440883
Ann Intern Med. 2010 Jul 6;153(1):8-18
pubmed: 20621900
Neth Heart J. 2020 Jul;28(7-8):396-405
pubmed: 32514935
Semin Thromb Hemost. 2000;26 Suppl 1:5-21
pubmed: 11011802
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
J Thromb Haemost. 2020 Aug;18(8):1859-1865
pubmed: 32459046
Sci China Life Sci. 2020 Mar;63(3):364-374
pubmed: 32048163
Thromb Haemost. 2010 Mar;103(3):572-85
pubmed: 20135071
J Clin Invest. 2020 Aug 3;130(8):3950-3953
pubmed: 32459663
Lancet Haematol. 2020 Jun;7(6):e438-e440
pubmed: 32407672
Front Immunol. 2019 Jul 26;10:1731
pubmed: 31402914
Chest. 2011 Sep;140(3):706-714
pubmed: 21436241
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32329756
J Trauma Acute Care Surg. 2020 Sep;89(3):448-452
pubmed: 32427774
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Clin Virol. 2020 Jun;127:104354
pubmed: 32305882
Lancet. 2020 May 16;395(10236):1546
pubmed: 32423583
J Thromb Thrombolysis. 2020 Aug;50(2):287-291
pubmed: 32445064
J Trauma Acute Care Surg. 2020 Sep;89(3):453-457
pubmed: 32427773
Br J Dermatol. 2020 Oct;183(4):729-737
pubmed: 32562567
Inflamm Res. 2001 Dec;50(12):581-4
pubmed: 11822782
J Thromb Haemost. 2020 Jul;18(7):1738-1742
pubmed: 32302438
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267
pubmed: 32209890
Blood. 2018 Apr 26;131(17):1903-1909
pubmed: 29483100
J Pathol. 2001 Jan;193(1):134-40
pubmed: 11169526
Histopathology. 2020 Aug;77(2):186-197
pubmed: 32443177
J Thromb Thrombolysis. 2020 Aug;50(2):298-301
pubmed: 32476080
Eur J Clin Pharmacol. 2015 Aug;71(8):921-9
pubmed: 26071276
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Circ Res. 2016 Feb 19;118(4):620-36
pubmed: 26892962
J Thromb Haemost. 2020 Aug;18(8):2067-2068
pubmed: 32407600
Clin Pharmacol Ther. 2019 Jan;105(1):219-228
pubmed: 29696643
Thromb Res. 2020 Aug;192:152-160
pubmed: 32485418
N Engl J Med. 2020 Apr 30;382(18):e43
pubmed: 32294340
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379
pubmed: 32242738
Int J Cardiol. 2007 Mar 20;116(2):174-9
pubmed: 16901564
Int J Lab Hematol. 2020 Jun;42 Suppl 1:19-20
pubmed: 32311843
Crit Care. 2018 Mar 8;22(1):60
pubmed: 29519254
N Engl J Med. 2018 Sep 20;379(12):1118-1127
pubmed: 30145946
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712
N Engl J Med. 2016 Aug 11;375(6):534-44
pubmed: 27232649
J Med Econ. 2019 Oct;22(10):1063-1072
pubmed: 31314619
Thromb Haemost. 2020 Jun;120(6):937-948
pubmed: 32316065

Auteurs

Grigoris T Gerotziafas (GT)

Hematology and Thrombosis Center, Hôpital Tenon, Hôpitaux Universitaires de l'Est Parisien, Assistance Publique Hôpitaux de Paris, Faculté de Médecine, Sorbonne Université, Paris, France.
Research Group Cancer, Haemostasis and Angiogenesis," INSERM U938, Centre de Recherche Saint-Antoine, Institut Universitaire de Cancérologie, Faculty of Medicine, Sorbonne University, Paris, France.

Mariella Catalano (M)

Research Center on Vascular Disease & Angiology Unit, Department of Biomedical Science, L Sacco Hospital, University of Milan, Milan, Italy.

Mary-Paula Colgan (MP)

Department of Vascular Surgery, St. James's Hospital/Trinity College Dublin, Dublin, Ireland.

Zsolt Pecsvarady (Z)

Department of Vascular Medicine, Flor Ferenc Teaching Hospital, Kistarcsa, Hungary.

Jean Claude Wautrecht (JC)

Service de Pathologie Vasculaire, Hôpital ERASME, Université Libre de Bruxelle, Brussels, Belgium.

Bahare Fazeli (B)

Immunology Department, Avicenna (Bu-Ali) Research Institute, Mashhad University of Medical Sciences, Iran.

Dan-Mircea Olinic (DM)

Medical Clinic No. 1, University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Katalin Farkas (K)

Department of Angiology, St. Imre University Teaching Hospital, Budapest, Hungary.

Ismail Elalamy (I)

Hematology and Thrombosis Center, Hôpital Tenon, Hôpitaux Universitaires de l'Est Parisien, Assistance Publique Hôpitaux de Paris, Faculté de Médecine, Sorbonne Université, Paris, France.
Research Group Cancer, Haemostasis and Angiogenesis," INSERM U938, Centre de Recherche Saint-Antoine, Institut Universitaire de Cancérologie, Faculty of Medicine, Sorbonne University, Paris, France.
Department of Obstetrics and Gynecology, I.M.Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Anna Falanga (A)

Department of Immunohematology and Transfusion Medicine, & the Thrombosis and Hemostasis Center, Hospital Papa Giovanni XXIII, Bergamo, Italy.

Jawed Fareed (J)

Department of Pathology, Loyola University Medical Center, Maywood, Illinois, United States.

Chryssa Papageorgiou (C)

Service Anesthésie, Réanimation et Médecine Périopératoire, Hôpital Tenon, Hôpitaux Universitaires de l'Est Parisien, Assistance Publique Hôpitaux de Paris, Faculté de médecine, Sorbonne Université, Paris, France.

Rosella S Arellano (RS)

Philippine Society of Vascular Medicine, Manila, Philippine.

Petros Agathagelou (P)

Department of Inrterventional Cardiology, American Heart Institute of Cyprus, Nicosia, Cyprus.

Darco Antic (D)

Clinic for Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Luciana Auad (L)

Medicina Vascular, Sanatorio Allende Córdoba, Ciencias Médicas, Universidad Católica de Córdoba, Argentina.

Ljiljana Banfic (L)

University Hospital Center, School of Medicine University of Zagreb, Croatia.

John R Bartolomew (JR)

Cleveland Clinic, Cleveland, Ohio, United States.

Bela Benczur (B)

Balassa Janos County Hospital, University Medical School, Szeged, Hungary.

Melissa B Bernardo (MB)

Philippine Society of Vascular Medicine, Manila, Philippine.

Francesco Boccardo (F)

Department of Cardio-Thoracic-Vascular and Endovascular Surgery, Unit of Lymphatic Surgery, IRCCS S. Martino Hospital, University of Genoa, Italy.

Renate Cifkova (R)

Department of Preventive Cardiology, Thomayer Teaching Hospital, Prague, Czech Republic.

Benilde Cosmi (B)

Angiology and Blood Coagulation, Department of Specialty, Diagnostic and Experimental Medicine, S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Sergio De Marchi (S)

Angiology Unit, Cardiovascular and Thoracic and Medicine Department, Verona University Hospital, Verona, Italy.

Evangelos Dimakakos (E)

Vascular Unit of 3rd Department of Internal Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Meletios A Dimopoulos (MA)

Hellenic Society of Hematology, Athens, Greece.
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Gabriel Dimitrov (G)

Research Center on Vascular Disease & Angiology Unit, Department of Biomedical Science, L Sacco Hospital, University of Milan, Milan, Italy.

Isabelle Durand-Zaleski (I)

Université de Paris, CRESS, INSERM, INRA, URCEco, AP-HP, Hôpital de l'Hôtel Dieu, Paris, France.

Michael Edmonds (M)

Diabetic Foot Clinic, King's College Hospital, London, United Kingdom.

Essam Abo El Nazar (EA)

Departement of Surgery, Ministry of Health, Saudi Arabia.

Dilek Erer (D)

Department of Cardiovascular Surgery, Faculty of Medicine, Gazi University, Besevler/Ankara, Turkey.

Omar L Esponda (OL)

Internal Medicine Department, Hospital Perea, Mayaguez, Puerto Rico, United States.

Paolo Gresele (P)

Section of Internal and Cardiovascular Medicine, Department of Medicine, -University of Perugia, Perugia, Italy.

Michael Gschwandtner (M)

MedizinischeUniverstiät Wien, Universitätsklinik für Innere Medizin II, Klinische Abteilung für Angiologie, Vienna, Austria.

Yongquan Gu (Y)

Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing China.

Mónica Heinzmann (M)

Medicina Vascular, Sanatorio Allende Córdoba, Ciencias Médicas, Universidad Católica de Córdoba, Argentina.

Naomi M Hamburg (NM)

The Whitaker Cardiovascular Institute Department of Medicine Boston University School of Medicine, Boston, Massachusetts, United States.

Amer Hamadé (A)

Vascular Medicine Unit, Internal Medicine Department, King Fahad University Hospital, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Noor-Ahmed Jatoi (NA)

Department Vascular Medicine, Mulhouse Hospital Center, Mulhouse, France.

Oguz Karahan (O)

Department of Cardiovascular Surgery, Medical School of Alaaddin Keykubat University, Alanya/Antalya, Turkey.

Debora Karetova (D)

Second Department of Medicine, Department of Cardiovascular Medicine, Charles University in Prague, Prague, Czech Republic.

Thomas Karplus (T)

Department of Vascular Medicine, Concord Repatriation General Hospital, Sydney, Australia.

Peter Klein-Weigel (P)

Klinik für Angiologie, Zentrum für Innere Medizin II, Ernst von Bergmann Klinikum, Potsdam, Germany.

Endre Kolossvary (E)

Department of Angiology, St. Imre University Teaching Hospital, Budapest, Hungary.

Matija Kozak (M)

Department for Vascular Diseases, Medical Faculty of Ljubljana, University Medical Center Ljubljana, Ljubljana, Slovenia.

Eleftheria Lefkou (E)

Board member of the Institute for the Study and Education on Thrombosis and Antithrombotic Therapy, Athens, Greece.

Gianfranco Lessiani (G)

Angiology Unit, Internal Medicine Department., Città Sant' Angelo Hospital, AUSL 03, Pescara, Italy.

Aaron Liew (A)

Portiuncula University Hospital, Soalta University Health Care Group, National University of Ireland Galway (NUIG), Galway, Ireland.

Antonella Marcoccia (A)

Unità di Medicina Vascolare e Autoimmunità, CRIIS-Centro di riferimento interdisciplinare per la Sclerosi Sistemica, Rome, Italy.

Peter Marshang (P)

Department of Internal Medicine, Central Hospital of Bolzano, Bolzano, Italy.

George Marakomichelakis (G)

Angiology Unit, Evangelismos General Hospital, Athens, Greece.

Jiri Matuska (J)

MATMED s.r.o., Private Angiology Facility, Hodonin, Czech Republic.

Luc Moraglia (L)

Angiologie Centre Cours du Médoc, Médecine Vasculaire Travail, Bordeaux, France.

Sergio Pillon (S)

UOSD Angiology, San Camillo-Forlanini Hospital, National Health Institute ISS, Rome, Italy.

Pavel Poredos (P)

Medical Association of Slovenia and SMA, Slovenia Academic Research Centre, Slovenian Medical Academy, Ljubljana, Slovenia.

Manlio Prior (M)

Angiology Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

David Raymund K Salvador (DRK)

Philippine Society of Vascular Medicine, Manila, Philippine.

Oliver Schlager (O)

Division of Angiology, Department of Internal Medicine 2, Medical University of Vienna, Vienna, Austria.

Gerit Schernthaner (G)

Division of Angiology, Department of Internal Medicine 2, Medical University of Vienna, Vienna, Austria.

Alexander Sieron (A)

Department of Internal Medicine, Angiology and Physical Medicine, Medical University of Silesia, Katowice, Poland.
Specialist Hospital, Bytom, Jan Długosz University in Częstochowa, Częstochowa, Poland.

Jonas Spaak (J)

Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Stockholm County, Sweden.

Alex Spyropoulos (A)

Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, The Feinstein Institute for Medical Research, New York, New York, United States.

Muriel Sprynger (M)

Cardiology Department, University Hospital Sart Tilman, Liege, Belgium.

Dusan Suput (D)

Center for Clinical Physiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Agata Stanek (A)

Department of Internal Medicine, Angiology and Physical Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Bytom, Poland.

Viera Stvrtinova (V)

Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.

Andrzej Szuba (A)

Department of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, Poland.

Alfonso Tafur (A)

Vascular Medicine University of Chicago, Northshore Cardiovascular Institute, Skokie, Illinois, US Army.

Patrick Vandreden (P)

Research Group Cancer, Haemostasis and Angiogenesis," INSERM U938, Centre de Recherche Saint-Antoine, Institut Universitaire de Cancérologie, Faculty of Medicine, Sorbonne University, Paris, France.

Panagiotis E Vardas (PE)

Medical School of Crete, University of Crete and Heart Sector, Hellenic Healthcare Group, Athens, Greece.

Dragan Vasic (D)

Department of Noninvasive vascular laboratory, Clinic of Vascular and Endovascular Surgery, Clinical Centre of Serbia, Belgrade, Serbia.

Miikka Vikkula (M)

Human Molecular Genetics, de Duve Institute, University of Louvain, Brussels, Belgium.

Paul Wennberg (P)

Department of Cardiovascular Medicine, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota, United States.

Zhenguo Zhai (Z)

Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Peking University Health Science Center, Capital Medical University, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH